Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

On March 21, 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i(2) = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Dompé. The TFOS i(2) meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i(2) meeting.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ocul Surf

Title: The ocular surface

Publisher: Elsevier BV

ISSN (Electronic): 1937-5913

ISSN (Print): 1542-0124

Publication date (Electronic): Apr 2016

Volume: 14

Issue: 2

Affiliations

[1 ] Schepens Eye Research Institute, Massachusetts Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

[2 ] Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, and International Brain Research Organization, Alicante, Spain.

[3 ] Complutense University of Madrid and Hospital Clinico San Carlos, Madrid, Spain.

[4 ] University of Oxford, Oxford, UK.

[5 ] Section of Ophthalmology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.

[6 ] School of Optometry, University of Alabama, Birmingham, AL, USA.

[7 ] PharmaLogic Development, Inc., San Rafael, CA, USA.

[8 ] Laboratory for Experimental Ophthalmology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

[9 ] School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, Australia.

[10 ] Ophthalmic Research Group, Life and Health Sciences, Aston University, Birmingham, UK.

[11 ] Schepens Eye Research Institute, Massachusetts Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address: david.sullivan@schepens.harvard.edu.

Article

Publisher Item ID: S1542-0124(15)00205-0

DOI: 10.1016/j.jtos.2015.11.003

PubMed ID: 26774910

SO-VID: 241992ba-5e0f-4983-a0c8-86cc8044541a

History

Keywords: Clinical trials,Dry Eye WorkShop II (DEWS II),Tear Film & Ocular Surface Society,drug development,dry eye disease (DED),i(2) = initiating innovation series

Data availability:

Keywords: Clinical trials, Dry Eye WorkShop II (DEWS II), Tear Film & Ocular Surface Society, drug development, dry eye disease (DED), i(2) = initiating innovation series

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.